Your browser doesn't support javascript.
loading
The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma.
Fishbein, Lauren; Del Rivero, Jaydira; Else, Tobias; Howe, James R; Asa, Sylvia L; Cohen, Debbie L; Dahia, Patricia L M; Fraker, Douglas L; Goodman, Karyn A; Hope, Thomas A; Kunz, Pamela L; Perez, Kimberly; Perrier, Nancy D; Pryma, Daniel A; Ryder, Mabel; Sasson, Aaron R; Soulen, Michael C; Jimenez, Camilo.
Afiliação
  • Fishbein L; From the Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO.
  • Del Rivero J; Developmental Therapeutics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Else T; Division of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI.
  • Howe JR; Division of Surgical Oncology and Endocrine Surgery, Department of Surgery, University of Iowa Carver College of Medicine, Iowa City, IA.
  • Asa SL; Department of Pathology, University Hospitals Cleveland Medical Center and University Health Network, Toronto, Case Western Reserve University, Cleveland, OH.
  • Cohen DL; Renal Division, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
  • Dahia PLM; Division of Hematology and Medical Oncology, Department of Medicine, University of Texas Health San Antonio, San Antonio, TX.
  • Fraker DL; Division of Endocrine and Oncologic Surgery, Department of Surgery, University of Pennsylvania and Abramson Cancer Center, Philadelphia, PA.
  • Goodman KA; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Hope TA; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA.
  • Kunz PL; Division of Oncology, Department of Medicine, Yale School of Medicine, New Haven, CT.
  • Perez K; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Perrier ND; Division of Surgery, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Pryma DA; Department of Radiology and Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
  • Ryder M; Endocrine Oncology Tumor Group, Division of Medical Oncology, Mayo Clinic, Rochester, MN.
  • Sasson AR; Division of Surgical Oncology, Department of Surgery, Stony Brook University Medical Center, Stony Brook, NY.
  • Soulen MC; Department of Radiology, University of Pennsylvania, Philadelphia, PA.
  • Jimenez C; Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX.
Pancreas ; 50(4): 469-493, 2021 04 01.
Article em En | MEDLINE | ID: mdl-33939658
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Paraganglioma / Feocromocitoma / Tumores Neuroendócrinos / Neoplasias das Glândulas Suprarrenais País/Região como assunto: America do norte Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Colômbia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Paraganglioma / Feocromocitoma / Tumores Neuroendócrinos / Neoplasias das Glândulas Suprarrenais País/Região como assunto: America do norte Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Colômbia